iCAD Introduces ProFound AI™ for 2D Mammography in Europe

Home/Client News/iCAD Introduces ProFound AI™ for 2D Mammography in Europe

iCAD Introduces ProFound AI™ for 2D Mammography in Europe

NASHUA, N.H. and LILLE, France, June 13, 2019 (GLOBE NEWSWIRE) — iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the launch of ProFound AI™ for 2D Mammography in Europe. This software is the latest addition to iCAD’s deep-learning, artificial intelligence platform and follows the launch of ProFound AI™ for Digital Breast Tomosynthesis (DBT), which was CE Marked in March 2018 and FDA cleared in December 2018. ProFound AI for 2D Mammography and ProFound AI for DBT will both be featured in the iCAD exhibition booth (#24) at the Société Française d’Imagerie de la FEMme (SIFEM) medical conference from June 13-15, 2019 at the Grand Palais in Lille, France.

By | 2019-06-13T15:17:41+00:00 June 13th, 2019|Client News|Comments Off on iCAD Introduces ProFound AI™ for 2D Mammography in Europe